Ancora Heart

We are dedicated to helping people with heart failure feel better and live longer.

09/02/2025

This past weekend, François Gaudier and Nataša Panić from our team attended the ESC Congress in Madrid.🇪🇸They’ve come back energized from their discussions and insightful conversations with physicians and peers about the System and .

European Society of Cardiology

08/13/2025

Congrats University Clinical Center Niš for yet another successful implant of the Transcatheter Ventricular Restoration System for ! Thank you to Prof. Svetlana Apostolovic, Drs. Milan Živković, Bojan Maričić and Jelena Milošević, and nurses Jelena Perišić and Ana Ilić for advancing the CORCINCH-HF .

08/11/2025

Last week, the Advocate Christ Medical Center from Advocate Health Care completed their first implant of the Transcatheter Ventricular Restoration System for the CORCINCH-HF . Thanks Drs. Abdul Ghani, Shermeen Memon, Joseph Ayat, clinical research coordinators, Paul Maze, Bryan Kowalski, and registered nurses Betsy Niebert, and Christine Cortelloni for helping further research for this potential treatment option.

07/30/2025

Congratulations Cardiovascular Center Frankfurt CVC for successfully implanting their first patient in the CORCINCH-HF clinical trial with the Transcatheter Ventricular Restoration System. Thank you to their great team including Prof. Horst Sievert, Dr. Pamela Ilioska-Damkoehler, Celina Peuster, Vladyslava Lytovchenko and Kristina Koberg! A special thank you to Dr. Oleg Polonetsky for being the medical proctor.

07/24/2025

Congrats Northwell Health Lennox Hill Hospital and Drs. Apurva Patel and Mei Chau for successfully completing training with the Transcatheter Ventricular Restoration System for ! We look forward to collaborating with your team and advancing the CORCINCH-HF .

07/21/2025

Congratulations Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" for successfully implanting the Transcatheter Ventricular Restoration System in a patient with ! We are grateful for the support for the CORCINCH-HF clinical trial from its fantastic team including Prof. Davide Capodanno, Drs. Maria Elena Di Salvo, Giuliano Costa, Giuseppe Leonardi, Maria Sanfilippo, Salvatore Scandura and Matteo Scalia.

07/18/2025

🇩🇪Congratulations Uniklinik Köln for being the first in Germany to successfully implant the Transcatheter Ventricular Restoration System in a CORCINCH-HF patient with ! Thanks for supporting the CORCINCH-HF clinical trial, Dr. Matti Adam, Prof. Roman Pfister, Dr. Maria Isabel Koerber and research coordinators Ana Heinrichs, Drs. Sascha Macherey-Meyer, Jan Althoff, and Leonhard Ritter.

07/14/2025

June was a busy and productive month! Read coverage of our announcement about reaching the first enrollment milestone of 250 patients in the pivotal CORCINCH-HF Study in the stories below.

🔗Cardiac Interventions Today: https://bit.ly/44AfS2u

🔗MassDevice: https://bit.ly/4lC9y1h

🔗Cardiovascular Business: https://bit.ly/3TX7OUB

🔗Cardiovascular News: https://bit.ly/40HPFOh

🔗Medical Device Developments: https://bit.ly/44zNDks

07/03/2025

Last week, we announced that the CORCINCH-HF evaluating the safety and effectiveness of the Transcatheter Ventricular Restoration System in patients with symptomatic HF with reduced ejection fraction (HFrEF) has reached its first enrollment milestone of 250 patients. The AccuCinch System was granted Breakthrough Device Designation by the U.S. Food and Drug Administration.

Learn more: https://bit.ly/4lbUIyu.

07/01/2025

An estimated 6.7 million adults in the U.S. live with heart failure, and about half have HFrEF. Our CORCINCH-HF pivotal trial, evaluating the Transcatheter Ventricular Restoration System for HFrEF, has reached its first enrollment milestone of 250 patients. The six-month safety and efficacy follow-up data of these patients will support our PMA application to the FDA.

06/27/2025

Thank you, Dr. Ulrich Jorde, for an insightful presentation at the NY Valves conference about the Transcatheter Ventricular Restoration System and the CORCINCH-HF . We appreciate your commitment to advancing this potential treatment option for people with .

Cardiovascular Research Foundation

06/25/2025

The Transcatheter Ventricular Restoration System is designed to reduce the size of the left ventricle, reduce ventricular wall stress, and support and strengthen the heart wall. This week, we announced that the CORCINCH-HF evaluating the safety and effectiveness of the AccuCinch System in patients who have symptomatic HF with reduced ejection fraction (HFrEF) reached its first enrollment milestone of 250 patients.

Address

4001 Burton Drive
Santa Clara, CA
95054

Website

http://www.ancoraheart.com/

Alerts

Be the first to know and let us send you an email when Ancora Heart posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Santa Clara?